Tania Dempsey answering questions about the use of GLP-1 and GIP targeting treatments like Ozempic and Mounjaro and such, in MCAS patients
In Denmark, about 70% of people who use weight loss medications are women and so it is inevitable that some may take it without realizing they are pregnant. However, she said more research is needed, and it is still too early to change the recommendation that GLP-1 RAs should be stopped before pregnancy, or to change counseling based on the reason the drugs were prescribed
Furthermore, Methylcobalamin has been used to enhance cognitive function in elderly patients, providing a potential treatment option for age-related cognitive decline
2014;99:E231724
In the alpha cells of the islets, GLP-1 receptor activation suppresses glucagon secretion, a process mediated by somatostatin release from adjacent delta cells
Safetywise, larazotide has generally shown a favorable profile in trials, with adverse events not significantly different from placebo and mainly involving mild GI symptoms
